If you have been diagnosed with a type of skin cancer called melanoma, Yervoy™ (ipilimumab) may help slow down the progression of your disease. This prescription chemotherapy drug is specifically approved for use when the cancer has spread to other areas of the body or cannot be surgically treated. It is approved for use in adults age 18 and older.
A clinical study has shown that Yervoy can extend survival in people who have advanced melanoma or who have stopped responding to other anticancer treatments. In this study, people given Yervoy survived an average of 10 months on treatment, compared with 6.5 months for people not given it.
(Click Yervoy Uses for a closer look at how Yervoy can help treat melanoma in adults. This article also explains how this medication works, discusses whether there are off-label uses, and talks about whether it is safe for use in children.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
FDA approves new treatment for a type of late-stage skin cancer (3/25/2011). FDA Web site. Available at: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm1193237.htm. Accessed November 4, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click